Elos Medtech signs agreement with global healthcare company to expand production capacity
Elos Medtech signs agreement with global healthcare company to expand production capacity in China. The annual value of the deal is approximately CNY 90 million by 2025. Elos Medtech will invest approximately CNY 50 million in the next 2 years. Elos Medtech has signed an amendment to an existing agreement with a global healthcare customer active in the fields of diabetes and other chronic diseases, to provide an additional CNY 90 million in annual production output by the end of 2025. The additional volume will be made by the production site in Tianjin for the Chinese market. Elos